Sep 04,2019

Liva Healthcare wins EU funding to help pregnant women at risk of Type 2 diabetes

Liva Healthcare has secured €603,405 in funding from the EU Horizon 2020 programmes to be part of the "Impact Diabetes Bump 2 Baby" (IDB2B) research project. The digital health coaching app, headquartered in London and Copenhagen, will work toward finding the best way to treat mothers at risk of developing Type 2 diabetes.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Sep 09,2019

DIAMONTECH SUCCESSFULLY COMPLETES A FINANCING ROUND OF OVER 7 MILLION EUROS

DiaMonTech GmbH, a young, innovative medical technology company, has successfully completed its Series A financing round. The company will receive a total of more than 7 million euros. The lead investor for this growth financing is Bioventure, an investor specializing in biotech and life sciences. In addition, DiaMonTech has gained two family offices as new investors. Existing shareholders - such as IBB Beteiligungsgesellschaft with the VC Fonds Technologie Berlin - also participated in the financing round.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Sep 17,2019

One Drop Launches Global Commercial Partnership with Bayer and Announces $40M in Series B Financing

One Drop, a leader in the development of digital therapeutic solutions for diabetes and other chronic conditions, today announced $40 million in Series B financing, led by Bayer, one of the largest pharmaceutical companies in the world. Bayer has also entered a commercial licensing agreement to use One Drop’s platform in Bayer’s global bio-digital efforts in therapeutic areas such as oncology, cardiovascular disease, and women’s health. Stefan Oelrich, the President of Bayer Pharmaceuticals, will join One Drop’s Board of Directors.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Oct 10,2019

Omada Health receives strategic investment from Intermountain Ventures

Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 05,2019

Bayer Invests in UK Health Tech Firm Medopad

AI start-up Medopad, a crucial Health tech partner of Tencent has received $25m (£19.3m) as Series-B funding from German Pharmaceutical giant Bayer. Medopad's focus is on efforts to build digital biomarkers to diagnose diseases that are not detected easily by doctors or blood tests. The collected data from patients will be used by Medopad to analyze the progress of diseases. Alzheimer‘s and Diabetes are the other focus areas.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 02,2019

Diabeloop Completes Record-Breaking European Fundraising Effort With Its Autonomous Diabetes Management Solutions

Diabeloop announced today that it has completed a 31-million-euro Series B round of funding, setting a European fundraising record in the area of therapeutic artificial intelligence. This funding will allow Diabeloop to accelerate its international commercial deployment in both Europe and the US, and will support the award-winning company’s innovative programs.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 20,2019

DarioHealth Announces Closing of $21.3 Million Private Placement

DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that it has closed on a private placement of convertible preferred stock to institutional and private investors. The Company received aggregate gross proceeds of approximately $21.3 million, before deducting placement agent fees and other offering expenses payable by the Company.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Jan 08,2018

Glucose monitor maker Intuity Medical brings in $40M

Fremont, California-based Intuity Medical, a diabetes management technology company, announced that it will be receiving $40 million in equity financing from several of its previous investors, including Accuitive Medical Ventures, Investor Growth Captial, KCK Group, affiliates of Luther King Capital Management, PTV Healthcare Capital, US Venture Partners, and Versant Ventures.

FUNDING VENTURE ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 08,2018

Fitbit invests $6M in glucose monitoring startup Sano

Fitbit has recently invested $6 million in San Fransisco-based Sano, a company developing a mobile app and sensor that will allow users to continuously monitor blood glucose levels, multiple publications have confirmed.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Mar 28,2018

Bigfoot Biomedical closes Series B financing round with $55M

A diabetes startup that uses artificial intelligence, Bigfoot Biomedical, has just announced that it scored a total of $55 million in Series B equity financing with new investments from Abbott and other existing funders.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING